GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $27.24 and traded as low as $26.55. GENMAB A/S/S shares last traded at $26.90, with a volume of 502,471 shares.
GENMAB A/S/S Stock Up 1.5 %
The stock has a 50 day moving average price of $27.24 and a 200 day moving average price of $28.09.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Featured Articles
- Five stocks we like better than GENMAB A/S/S
- Roth IRA Calculator: Calculate Your Potential Returns
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- How to Use the MarketBeat Dividend Calculator
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
